Subgroup specific protection of mice from respiratory syncytial virus infection with peptides encompassing the amino acid region 174-187 from the G glycoprotein: The role of cysteinyl residues in protection

Vaccine

Volumn 15, Issue 4, 1997, Pages 423-432

  Simard, Claire ^a   Nadon, Francine ^a   Séguin, Cécile ^a   Thien, Nguyen Ngoc ^b   Binz, Hans ^b   Basso, Johnny ^c   Laliberté, Jean François ^a   Trudel, Michel ^a  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b Centre d'Immunologie Pierre Fabre   (France)

^c EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

G protein; respiratory syncytial virus (RSV); synthetic vaccine

Indexed keywords

GLYCOPROTEIN; RECOMBINANT PROTEIN; RESPIRATORY SYNCYTIAL VIRUS VACCINE; SYNTHETIC PEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; IMMUNIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS INFECTION;

EID: 0030990506     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00189-8     Document Type: Article

References (39)

1. McIntosh, K. and Chanock, R.M. Respiratory syncytial virus. In: Virology, 2nd edn (Eds Fields, B.N., Knipe D.M., et al.). Raven Press, New York, 1990, pp. 1045-1072
2. Kim, H.W., Arrobio, J.O. and Brandt, C.D. et al. Epidemiology of respiratory syncytial virus infection in Washington, D.C., I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. Am. J. Epidemiol. 1973, 98, 216-225
3. Mufson, M.A., Levine, H.D., Wash, R.E., Mocega-Gonsales, H.E. and Krause, H.H. Epidemiology of respiratory syncytial virus infection among infants and children in Chicago. Am. J. Epidemiol. 1973, 98, 289-300
4. Gilchrist, S., Torok, T.J., Gary, H.E., Alexander, J.P. and Anderson, L.J. National surveillance for respiratory syncytial virus, United States, 1985-1990. J. Infect. Dis. 1994, 170, 986-990
5. Long, C.E., Mcbride, J.T. and Hall, C.B. Sequelae of respiratory syncytial virus infections - a role for intervention studies. Am. J. Resp. Critical Care Med. 1995, 151, 1678-1681
6. Sigurs, N., Bjamason, R., Sigurbergsson, F., Kjellman, B. and Bjorksten, B. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics 1995, 95, 500-505
7. Kim, H.W., Canchola, J.G. and Brandt, C.D. et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 1969, 89, 422-434
8. Mcintosh, K. and Fishaut, J.M. Immunopathologic mechanism in lower respiratory tract disease of infants due to respiratory syncytial virus. Prog. Med. Virol. 1980, 26, 94-118
9. Anderson, L.J., Heirholzer, J.C. and Tsou, C. et al. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J. Infect. Dis. 1985, 151, 626-633
10. Gimenez, H.B., Hardman, N., Keir, H.M. and Cash, P. Antigenic variation between respiratory syncytial virus isolates. J. Gen. Virol. 1986, 67, 863-870
11. Mufson, M.A., Örvell, C., Rafnar, B. and Norrby, E. Two distinct subtypes of respiratory syncytial virus. J. Gen. Virol. 1985, 66, 2111-2124
12. Collins, P.L., Purcell, R.H., London, W.T., Lawrence, L.A., Chanock, R.M. and Murphy, B.R. Evaluation in chimpanzees of vaccinia virus recombinants that express the surface glycoproteins of human respiratory syncytial virus. Vaccine 1990, 8, 164-168
13. Connors, M., Kulkarni, A.B. and Collins, P.L. et al. Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8+ T-cells, while that induced by Vac-F of Vac-G recombinants is mediated by antibodies. J. Virol. 1992, 66, 1277-1281
14. Connors, M., Collins, P.L., Firestone, C.-Y. and Murphy, B.R. Respiratory syncytial virus (RSV) F-protein, G-protein, M2-protein (22K), and N-proteins each induce resistance to RSV challenge, but resistance induced by M2-proteins and N-proteins is relatively short-lived. J. Virol. 1991, 65, 1634-1637
15. Elango, N., Prince, G.A., Murphy, B.R., Venkatesan, S., Chanock, R.M. and Moss, B.R. Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein. Proc. Natl Acad. Sci. U.S.A. 1986, 83, 1906-1910
16. Johnson, P.R.Jr, Olmsted, R.A. and Prince, G.A. et al. Antigenic relatedness between glycoproteins of human respiratory syncytial virus A and B: evaluation of the contributions of the F and G glycoproteins to immunity. J. Virol. 1987, 61, 3163-3166
17. Murphy, B.R., Sotnikov, A. and Paradiso, PR. et al. Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease. Vaccine 1989, 7, 533-540
18. Norrby, E., Mufson, M.A. and Sheshberadaran, H. Structural differences between subtype A and B strains of respiratory syncytial virus. J. Gen. Virol. 1986, 67, 2721-2729
19. Olmsted, R.A., Buller, R.M.L. and Collins, P.L. et al. Evaluation in non-human primates of the safety, immunogenicity and efficacy of recombinant vaccinia viruses expressing the F and G glycoprotein of respiratory syncytial virus. Vaccine 1988, 6, 519-524
20. Stott, E.J., Ball, L.A., Young, K.K., Furze, J. and Wertz, G.W. Human respiratory syncytial virus glycoprotein G expressed from a recombinant vaccinia virus vector protects mice against live-virus challenge. J. Virol. 1986, 60, 607-613
21. Stott, E.J., Taylor, G. and Ball, L.A. et al. Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus. J. Virol. 1987, 61, 3855-3861
22. Sullender, W.M., Anderson, K. and Wertz, G.W. The respiratory syncytial virus subgroup attachment glycoprotein: analysis of sequence, expression from a recombinant vector, and evaluation as an immunogen against homologous and heterologous subgroup virus challenge. Virology 1990, 178, 195-203
23. Walsh, E.E., Hall, C.B., Briselli, M., Brandriss, M.W. and Schlesinger, J.J. Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection. J. Infect Dis. 1987, 155, 1198-1204
24. Levine, S., Klaiber-Franco, R. and Paradiso, P.R. Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus. J. Gen. Virol. 1987, 68, 2521-2524
25. Johnson, P.R., Spriggs, M.K., Olmsted, R.A. and Collins, PL. The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins. Proc. Natl Acad. Sci. U.S.A. 1987, 84, 5626-5629
26. Cane, P.A., Matthews, D.A. and Pringle, C.R. Identification of variable domains of the attachment (G) protein of subgroup A respiratory syncytial viruses. J. Gen. Virol. 1991, 72, 2091-2096
27. Sullender, W.M., Mufson, M.A., Anderson, L.J. and Wertz, G. W Genetic diversity of the attachment protein of subgroup B respiratory syncytial viruses. J. Virol. 1991, 65, 5425-5434
28. Åkerlind-Stopner, B., Utter, G., Mufson, M.A., Orvell, C., Lerner, R.A. and Norrby, E. A subgroup-specific antigenic site in the G protein of respiratory syncytial virus forms a disulfide-bonded loop. J. Virol. 1990, 64, 5143-5148
29. Trudel, M., Nadon, F., Séguin, C. and Binz, H. Protection of Balb/c mice from respiratory syncytial virus infection by immunization with a synthetic peptide derived from the G-glycoprotein. Virology 1991, 185, 749-757
30. Simard, C., Nadon, R., Séguin, C. and Trudel, M. Evidence that the amino acid region 124-203 of the glycoprotein G from respiratory syncytial virus (RSV) constitutes a major part of the polypeptide domain that is involved in the protection against RSV infection. Antiviral Res. 1995, 28, 303-315
31. Olmsted, R.A., Murphy, B.R., Lawrence, L.A., Elango, N., Moss, B. and Collins, P.L. Processing, surface expression, and immunogenicity of carboxy-terminally truncated mutants of G protein of human respiratory syncytial virus. J. Virol. 1989, 63, 411-420
32. Schaaper, W.M.M., Lankhof, H., Puijk, W.C. and Meloen, R.H. Manipulation of anti-peptide immune response by varying the coupling of the peptide with the carrier protein. Mol. Immun. 1989, 26, 81-85
33. Studier, F.W., Rosenberg, A.H., Dunn, J.J. and Dubendorff, J.W. Use of T7 RNA polymerase to direct expression of cloned genes. Meth. Enzymol. 1990, 185, 60-89
34. Taylor, G., Stott, E.J. and Ferwie, B.F. et al. Monoclonal antibodies that protect against respiratory syncytial virus infection in mice. Immunology 1984, 52, 137-142
35. Trudel, M., Nadon, F., Séguin, C., Amarouch, A., Payment, P. and Gillam, S. E1 glycoprotein of rubella virus carries an epitope that binds a neutralizing antibody. J. Virol. Met. 1985, 12, 243-250
36. Corbeil, S., Séguin, C. and Trudel, M. Involvement of the complement system in the protection of mice from challenge with respiratory syncytial virus Long strain following passive immunization with monoclonal antibody 18A2B2. Vaccine 1996, 14, 521-525.
37. Åkerlind-Stopner, B., Utter, G., Norrby, E. and Mufson, M.A. Evaluation of subgroup-specific peptides of the G protein of respiratory syncytial virus for characterization of the immune response. J. Med. Virol. 1995, 47, 120-125
38. Piedra, P.A., Glenzen, W.P. and Kasel, J.A. et al. Safety and immunogenicity of the PFP vaccine against respiratory syncytial virus (RSV): the Western blot assay aids in distinguishing immune responses of the PFP vaccine from RSV infection. Vaccine 1995, 13, 1095-1101
39. Martingalardo, A., Fleischer, E. and Doyle, S.A. et al. Expression of the G-glycoprotein gene of human respiratory syncytial virus in Salmonella typhimurium. J. Gen. Virol. 1993, 74, 453-458